131 related articles for article (PubMed ID: 15029636)
1. Dornase in non-CF.
Ratjen F
Pediatr Pulmonol Suppl; 2004; 26():154-5. PubMed ID: 15029636
[No Abstract] [Full Text] [Related]
2. Rational use of mucoactive medications to treat pediatric airway disease.
Linssen RSN; Ma J; Bem RA; Rubin BK
Paediatr Respir Rev; 2020 Nov; 36():8-14. PubMed ID: 32653467
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant human DNase in conditions other than cystic fibrosis].
Kristensen K
Ugeskr Laeger; 2010 Feb; 172(8):616-9. PubMed ID: 20184817
[TBL] [Abstract][Full Text] [Related]
4. Who will benefit from DNase?
Rubin BK
Pediatr Pulmonol; 1999 Jan; 27(1):3-4. PubMed ID: 10023784
[No Abstract] [Full Text] [Related]
5. Dornase alpha compared to hypertonic saline for lung atelectasis in critically ill patients.
Youness HA; Mathews K; Elya MK; Kinasewitz GT; Keddissi JI
J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):342-8. PubMed ID: 22413805
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological and clinical profiles of Dornase alfa (Pulmozyme®) in the management of cystic fibrosis patients to improve pulmonary function].
Kokubo H; Hosatani S; Ichikawa M
Nihon Yakurigaku Zasshi; 2013 Apr; 141(4):213-9. PubMed ID: 23575427
[No Abstract] [Full Text] [Related]
7. Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates.
El Hassan NO; Chess PR; Huysman MW; Merkus PJ; de Jongste JC
Pediatrics; 2001 Aug; 108(2):468-70. PubMed ID: 11483817
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of atelectasis with Dornase alpha in a patient with congenital muscular dystrophy.
Crescimanno G; Marrone O
Rev Port Pneumol; 2014; 20(1):42-5. PubMed ID: 24095150
[TBL] [Abstract][Full Text] [Related]
9. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis.
Merkus PJ; de Hoog M; van Gent R; de Jongste JC
Eur Respir J; 2001 Oct; 18(4):734-7. PubMed ID: 11716180
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological impact on mucociliary clearance.
Verstraeten JM
Arch Monaldi; 1982; 37(1-2):37-58. PubMed ID: 6765046
[No Abstract] [Full Text] [Related]
11. Use of recombinant human DNase in a premature infant with recurrent atelectasis.
Küpeli S; Teksam O; Dogru D; Yurdakök M
Pediatr Int; 2003 Oct; 45(5):584-6. PubMed ID: 14521538
[No Abstract] [Full Text] [Related]
12. Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus.
Durward A; Forte V; Shemie SD
Crit Care Med; 2000 Feb; 28(2):560-2. PubMed ID: 10708200
[TBL] [Abstract][Full Text] [Related]
13. Persistent atelectasis in bronchopulmonary dysplasia.
Peroni DG; Boner AL
Paediatr Respir Rev; 2000 Sep; 1(3):294-5, 299. PubMed ID: 15326731
[No Abstract] [Full Text] [Related]
14. Clinical and in vitro effect of dornase alfa in mechanically ventilated pediatric non-cystic fibrosis patients with atelectases.
Riethmueller J; Kumpf M; Borth-Bruhns T; Brehm W; Wiskirchen J; Sieverding L; Ankele C; Hofbeck M; Baden W
Cell Physiol Biochem; 2009; 23(1-3):205-10. PubMed ID: 19255515
[TBL] [Abstract][Full Text] [Related]
15. Inhaled Dornase alfa (Pulmozyme) as a noninvasive treatment of atelectasis in mechanically ventilated patients.
Zitter JN; Maldjian P; Brimacombe M; Fennelly KP
J Crit Care; 2013 Apr; 28(2):218.e1-7. PubMed ID: 23266402
[TBL] [Abstract][Full Text] [Related]
16. Resolution of chronic atelectasis in a child with asthma after aerosolized recombinant human DNase.
Gershan WM; Rusakow LS; Chetty A; Splaingard ML
Pediatr Pulmonol; 1994 Oct; 18(4):268-9. PubMed ID: 7838629
[No Abstract] [Full Text] [Related]
17. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
[TBL] [Abstract][Full Text] [Related]
18. Dornase alfa in mechanically ventilated children with bronchiolitis: A retrospective cohort study.
Vettleson K; Heiberger A; Olgun G
Pediatr Pulmonol; 2023 Aug; 58(8):2283-2288. PubMed ID: 37204223
[TBL] [Abstract][Full Text] [Related]
19. DNase treatment in primary ciliary dyskinesia--assessment by nocturnal pulse oximetry.
ten Berge M; Brinkhorst G; Kroon AA; de Jongste JC
Pediatr Pulmonol; 1999 Jan; 27(1):59-61. PubMed ID: 10023793
[No Abstract] [Full Text] [Related]
20. Dornase alfa (Pulmozyme).
Wagener JS; Kupfer O
Curr Opin Pulm Med; 2012 Nov; 18(6):609-14. PubMed ID: 22990660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
